Loratadine as an Anti-inflammatory Agent Against Clostridium difficile Toxin B is a research paper published in The Journal of Infectious Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01-DK128142
National Institutes of Health
Grant: R21-AI137663
Crohn’s & Colitis Foundation
Grant: 623027
Natural responses to past North Atlantic Oscillations: Southern Iberian Peninsula vs. United Kingdom. Analogues for future environmental changes
Crohn’s & Colitis Foundation
Grant: 1042884
China Scholarship Council
Grant: 202008210019
NIAID NIH HHS
Grant: R21 AI137663
NIDDK NIH HHS
Grant: R01 DK128142
National Institutes of Health
Grant: 1R01DK128142-01A1
Oral elafin formulation for intestinal fibrosis
National Institutes of Health
Grant: 1R21AI137663-01A1
Orally active metabolite therapy against C. difficile infection
FWCI
1.84
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals